These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33673169)

  • 1. The
    Nowak H; Vornweg S; Rump K; Rahmel T; Unterberg M; Koos B; Schenker P; Viebahn R; Adamzik M; Bergmann L
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFKB1 promoter polymorphism: A new predictive marker of cytomegalovirus infection after kidney transplantation.
    Leone F; Gigliotti P; La Russa A; Lofaro D; Perri A; Vizza D; Lupinacci S; Toteda G; Bonofiglio M; Presta P; Talarico R; Aquino B; Bonofiglio R
    Transpl Infect Dis; 2019 Feb; 21(1):e13027. PubMed ID: 30431214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
    Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
    Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
    Zou YF; Wang F; Feng XL; Tao JH; Zhu JM; Pan FM; Su H
    Tissue Antigens; 2011 Jan; 77(1):9-17. PubMed ID: 21155719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
    Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
    Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between obesity and the NFKB1 - 94ins/delATTG promoter polymorphism in relation to incident acute coronary syndrome: a follow up study in three independent cohorts.
    Stegger JG; Schmidt EB; Berentzen TL; Tjønneland A; Vogel U; Rimm E; Sørensen TI; Overvad K; Jensen MK
    PLoS One; 2013; 8(5):e63004. PubMed ID: 23671649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional polymorphism of the NFKB1 gene promoter is not relevant in predisposition to celiac disease.
    Rueda B; Núñez C; López-Nevot MA; Paz Ruiz M; Urcelay E; De la Concha EG; Martín J
    Scand J Gastroenterol; 2006 Apr; 41(4):420-3. PubMed ID: 16635909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of association of a functional -94ins/delATTG NFKB1 promoter polymorphism with susceptibility and clinical expression of biopsy-proven giant cell arteritis in northwest Spain.
    Martin J; Perez-Armengol C; Miranda-Filloy JA; Vilchez JR; Lopez-Nevot MA; Garcia-Porrua C; Gonzalez-Gay MA
    J Rheumatol; 2006 Feb; 33(2):285-8. PubMed ID: 16465659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in Toll-like receptor and nuclear factor-kappa B genes and the risk of glioma.
    Kına I; Sultuybek GK; Soydas T; Yenmis G; Biceroglu H; Dirican A; Uzan M; Ulutin T
    Br J Neurosurg; 2019 Apr; 33(2):165-170. PubMed ID: 30450997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional polymorphism in NFKB1 promoter is related to the risks of oral squamous cell carcinoma occurring on older male areca (betel) chewers.
    Lin SC; Liu CJ; Yeh WI; Lui MT; Chang KW; Chang CS
    Cancer Lett; 2006 Nov; 243(1):47-54. PubMed ID: 16387424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between NFKB1 -94ins/delATTG promoter polymorphism and cancer risk: a meta-analysis.
    Zou YF; Yuan FL; Feng XL; Tao JH; Ding N; Pan FM; Wang F
    Cancer Invest; 2011 Jan; 29(1):78-85. PubMed ID: 21166501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional -94 insertion/deletion ATTG polymorphism in the promoter region of NFKB1 gene increases the risk of sporadic colorectal cancer.
    Mohd Suzairi MS; Tan SC; Ahmad Aizat AA; Mohd Aminudin M; Siti Nurfatimah MS; Andee ZD; Ankathil R
    Cancer Epidemiol; 2013 Oct; 37(5):634-8. PubMed ID: 23806437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Aquaporin3 Promoter Polymorphism -1431 A/G is Associated with Acute Graft Rejection and Cytomegalovirus Infection in Kidney Recipients Due to Altered Immune Cell Migration.
    Rump K; Rahmel T; Rustige AM; Unterberg M; Nowak H; Koos B; Schenker P; Viebahn R; Adamzik M; Bergmann L
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional promoter -94 ins/del ATTG polymorphism in NFKB1 gene is associated with bladder cancer risk in a Chinese population.
    Li P; Gu J; Yang X; Cai H; Tao J; Yang X; Lu Q; Wang Z; Yin C; Gu M
    PLoS One; 2013; 8(8):e71604. PubMed ID: 23977085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multifactorial analysis of the pregnancy outcomes in cytomegalovirus-infected women.
    Ding ZY; Xu F; Chen DZ; Meng XN; Xu TS; Lu MD; Zhuge HX
    Gynecol Obstet Invest; 2015; 80(2):106-12. PubMed ID: 25792174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional polymorphism of NFKB1 promoter may correlate to the susceptibility of gastric cancer in aged patients.
    Lo SS; Chen JH; Wu CW; Lui WY
    Surgery; 2009 Mar; 145(3):280-5. PubMed ID: 19231580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
    Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
    Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support.
    Vangsted AJ; Klausen TW; Gimsing P; Andersen NF; Abildgaard N; Gregersen H; Vogel U
    Haematologica; 2009 Sep; 94(9):1274-81. PubMed ID: 19734419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-κB1 promoter-94ins/delATTG polymorphisms correlate with the acute exacerbation of chronic obstructive pulmonary disease.
    Meng X; Zheng SQ; Wang JH; Zhang T
    J Thorac Dis; 2019 Dec; 11(12):5433-5439. PubMed ID: 32030262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma.
    Varga G; Mikala G; Andrikovics H; Koszarska M; Balassa K; Ádám E; Kozma A; Tordai A; Masszi T
    Br J Haematol; 2015 Mar; 168(5):679-88. PubMed ID: 25363231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.